31 related articles for article (PubMed ID: 23115227)
1. Effects of etravirine on the pharmacokinetics and pharmacodynamics of warfarin in rats.
John J; John M; Wu L; Hsiao C; Abobo CV; Liang D
Br J Pharmacol; 2013 Apr; 168(8):1851-8. PubMed ID: 23215758
[TBL] [Abstract][Full Text] [Related]
2. Considerations on the associations between antiretroviral regimen and changes in blood pressure in the D2EFT study.
Martinez E
Clin Infect Dis; 2024 Jun; ():. PubMed ID: 38943371
[No Abstract] [Full Text] [Related]
3. Impact of Paxlovid on international normalized ratio among patients on chronic warfarin therapy.
Muse O; Patell R; Lee M; Lech T; Guirguis M; Dodge L; Zwicker JI
Blood; 2022 Dec; 140(25):2757-2759. PubMed ID: 36240439
[No Abstract] [Full Text] [Related]
4. Stroke and Systemic Thromboembolism Prevention in People Living With Human Immunodeficiency Virus With Atrial Fibrillation: A Review of Its Implications for Clinical Practice.
Vizcarra P; Guillemi S; Eyawo O; Hogg RS; Montaner JS; Bennett M
CJC Open; 2019 Sep; 1(5):245-255. PubMed ID: 32159116
[TBL] [Abstract][Full Text] [Related]
5. Managing drug interactions in HIV-infected adults with comorbid illness.
Hughes CA; Tseng A; Cooper R
CMAJ; 2015 Jan; 187(1):36-43. PubMed ID: 25225224
[No Abstract] [Full Text] [Related]
6. Recurrent venous thrombosis despite 'optimal anticoagulation therapy' for antiphospholipid syndrome--could new oral anticoagulants solve the problem?
Balaban M; Stanrić V; Rincić G; Ledinsky M; Grbac L; Stancić N; Tomasić H
Acta Clin Croat; 2010 Dec; 49(4):469-77. PubMed ID: 21830460
[TBL] [Abstract][Full Text] [Related]
7. The effects of a nucleoside-sparing antiretroviral regimen on the pharmacokinetics of ritonavir-boosted darunavir in HIV type-1-infected patients.
Garvey L; Latch N; Erlwein OW; Mackie NE; Walsh J; Scullard G; McClure MO; Dickinson L; Back D; Winston A
Antivir Ther; 2010; 15(2):213-8. PubMed ID: 20386076
[TBL] [Abstract][Full Text] [Related]
8. Potential interaction involving warfarin and ritonavir.
Knoell KR; Young TM; Cousins ES
Ann Pharmacother; 1998 Dec; 32(12):1299-302. PubMed ID: 9876810
[TBL] [Abstract][Full Text] [Related]
9. A potential interaction between warfarin and atovaquone.
Hidalgo K; Lyles A; Dean SR
Ann Pharmacother; 2011 Jan; 45(1):e3. PubMed ID: 21189363
[TBL] [Abstract][Full Text] [Related]
10. Elevated international normalized ratio associated with use of dronedarone and warfarin.
Pogge EK; Haber SL
Ann Pharmacother; 2011 Sep; 45(9):e46. PubMed ID: 21811004
[TBL] [Abstract][Full Text] [Related]
11. A probable interaction between warfarin and the antiretroviral TRIO study regimen.
Liedtke MD; Vanguri A; Rathbun RC
Ann Pharmacother; 2012 Nov; 46(11):e34. PubMed ID: 23115227
[TBL] [Abstract][Full Text] [Related]
12. Warfarin-antiretroviral interactions.
Liedtke MD; Rathbun RC
Ann Pharmacother; 2009 Feb; 43(2):322-8. PubMed ID: 19196837
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
